Novo Nordisk Live(@NovoNordiskLive):The global POSEIDON study assembles real‑world evidence from 18,000+ patients across 18 countries. Findings put the global burden of CV inflammation in HF on record.1 Learn more at ESC Congress 2026, Hall A2 Stand T100.

2026.08.13 07:48

The global POSEIDON study assembles real‑world evidence from 18,000+ patients across 18 countries. Findings put the global burden of CV inflammation in HF on record.1 Learn more at ESC Congress 2026, Hall A2 Stand T100.

677

轉發到社區

熱門用戶

1.9M 粉絲

30.6K 粉絲

126.5K 粉絲

230.9K 粉絲

547.1K 粉絲

206.9K 粉絲

4.1M 粉絲

11K 粉絲

180.5K 粉絲

348.3K 粉絲

99.9K 粉絲

41.6K 粉絲

256.9K 粉絲

188.4K 粉絲

1.4M 粉絲